Philippe Lopes-Fernandes is the Senior Vice-President, Head of Global Business Development & Alliance Management for Merck KGaA, Darmstadt, Germany. His team provides end-to-end transactions support to ensure execution of high-quality global deals for all Merck business units and all stages of development, from early technology to clinical stage and marketed products.
Philippe is a results driven, innovative and committed executive with more than 20 years of experience in the pharmaceutical industry. He brings strong expertise in licensing and M&A, project management, marketing and sales, having directly negotiated key deals for Merck, including the in-licensing of Erbitux, the acquisition of Serono, the sale of Merck's generic business to Mylan, and most recently the alliance with Pfizer on PDL1. He has lived and worked in France, Portugal, Germany, Switzerland and the U.S.
Philippe holds a graduate degree in Business Administration from Institut Superieur de Gestion in Paris, France.